Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Drug Competition Hearing Planned For Senate Commerce Committee

Executive Summary

The Senate Commerce Committee is tentatively planning to hold a hearing on anticompetitive practices affecting generic drug marketing in April or May

You may also be interested in...



McCain/Schumer coalition has a name

"Coalition for a Competitive Pharmaceutical Market" is the name of a Blue Cross/ Blue Shield organized coalition in support of the McCain/Schumer generic drug legislation (1"The Pink Sheet" March 18, p. 45). General Motors noted during a May 8 Senate Health Committee hearing that it is a member of the group...

McCain/Schumer coalition has a name

"Coalition for a Competitive Pharmaceutical Market" is the name of a Blue Cross/ Blue Shield organized coalition in support of the McCain/Schumer generic drug legislation (1"The Pink Sheet" March 18, p. 45). General Motors noted during a May 8 Senate Health Committee hearing that it is a member of the group...

FTC To Testify On Generic Reform; Agency Report May Be “Months” Away

Patent licensing deals that relate exclusively to listing in FDA's "Orange Book" will attract antitrust scrutiny, FTC Office of Policy Planning Director Ted Cruz said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel